SynCore Biotechnology Co.,Ltd (4192.TWO)

TWD 34.6

(0.14%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 20.19 Million 15.85 Million 6.93 Million 13.33 Million 12.96 Million
Cost of Revenue 19.67 Million 6.77 Million 3.97 Million 7.14 Million 4.7 Million
Gross Profit 521 Thousand 9.08 Million 2.96 Million 6.19 Million 8.26 Million
Operating Expenses 46.02 Million 200.55 Million 461.58 Million 401.83 Million 424.85 Million
Selling, General and Administrative Expenses 42.08 Million 43.32 Million 38.62 Million 38.62 Million 44.76 Million
Research and Development Expenses 3.93 Million 157.23 Million 422.96 Million 363.21 Million 380.08 Million
Other Expenses - 3.65 Million 1.03 Million -1.12 Million -
Cost and Expenses 65.69 Million 207.33 Million 465.55 Million 408.98 Million 429.55 Million
Operating Income -45.5 Million -186.39 Million -456.56 Million -395.53 Million -416.58 Million
Interest Expense 784 Thousand 2.27 Million 2.03 Million 3.38 Million 2.03 Million
Income Tax Expense - - - - -
Earnings before Tax -38.17 Million -188.66 Million -458.59 Million -398.91 Million -408.63 Million
Net Income -38.17 Million -188.66 Million -458.59 Million -398.91 Million -408.63 Million
Earnings Per Share Basic -1.19 -6.14 -14.87 -14.12 -16.98
Earnings Per Share Diluted -1.19 -6.14 -14.87 -14.12 -16.98
Weighted Average Shares Outstanding 32.05 Million 30.74 Million 30.84 Million 28.25 Million 24.06 Million
Weighted Average Shares Outstanding (Diluted) 32.05 Million 30.74 Million 30.84 Million 28.25 Million 24.06 Million
Gross Margin 0.03 0.57 0.43 0.46 0.64
EBIT Margin -0.88 -9.23 -58.24 -25.43 -31.78
Profit Margin -1.89 -11.90 -66.09 -29.91 -31.51
EBITDA -17.72 Million -146.32 Million -404.13 Million -339.06 Million -353.36 Million
Earnings Before Tax Margin -2.25 -11.75 -65.80 -29.66 -32.13

Income Statement Charts